The LEARNS trial – which started earlier this year – is using smartphone and wearable technologies to monitor disease progression in Parkinson's patients and find ways to use digital ...

Parkinson’s disease is a progressive neurological disorder that affects millions of people worldwide, including 1,500 people ...

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Some Diabetes Drugs Tied to ...

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Researchers Develop Analytical ...

Researchers have developed a method to analyze extracellular vesicles (EVs) in blood for early detection of Parkinson’s disease (PD). By isolating EVs and assessing their contents, the team identified ...

Alimetry has raised an oversubscribed US $18m A2 financing round to commercialize its wearable gut health monitoring device ... journey is slow and poor for patients, causing them to suffer ...

Smart watches and wearable tech will be handed to millions of people under a 10-year plan to save the NHS. Devices to track blood pressure, glucose spikes and even monitor how cancer patients are ...

However, specific dopaminergic stimulants that act on the central nervous system ... disease and who could benefit from a DaTscan as a screening method. Current research continues to investigate the ...

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

How Is a DaTscan Used to Diagnose Parkinson's Disease? Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute for professional ...

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...

Objective Develop an objective, multi-modal digital platform to remotely measure clinical changes and predict outcomes in patients with Parkinson’s disease (PD) and dementia using a smartphone ...